CureVac NV (CVAC)
2.64
+0.12
(+4.76%)
USD |
NASDAQ |
May 01, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
CureVac Market Cap: 592.17M for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 565.25M |
| April 29, 2024 | 565.25M |
| April 26, 2024 | 522.63M |
| April 25, 2024 | 518.15M |
| April 24, 2024 | 563.01M |
| April 23, 2024 | 583.19M |
| April 22, 2024 | 567.49M |
| April 19, 2024 | 547.31M |
| April 18, 2024 | 547.31M |
| April 17, 2024 | 576.47M |
| April 16, 2024 | 597.77M |
| April 15, 2024 | 594.41M |
| April 12, 2024 | 652.73M |
| April 11, 2024 | 663.94M |
| April 10, 2024 | 661.70M |
| April 09, 2024 | 666.19M |
| April 08, 2024 | 688.62M |
| April 05, 2024 | 686.38M |
| April 04, 2024 | 663.94M |
| April 03, 2024 | 652.73M |
| April 02, 2024 | 646.00M |
| April 01, 2024 | 668.43M |
| March 28, 2024 | 679.65M |
| March 27, 2024 | 684.13M |
| March 26, 2024 | 659.46M |
| Date | Value |
|---|---|
| March 25, 2024 | 706.56M |
| March 22, 2024 | 684.13M |
| March 21, 2024 | 681.89M |
| March 20, 2024 | 684.13M |
| March 19, 2024 | 659.46M |
| March 18, 2024 | 720.02M |
| March 15, 2024 | 740.21M |
| March 14, 2024 | 745.88M |
| March 13, 2024 | 754.84M |
| March 12, 2024 | 763.80M |
| March 11, 2024 | 752.60M |
| March 08, 2024 | 768.28M |
| March 07, 2024 | 745.88M |
| March 06, 2024 | 734.68M |
| March 05, 2024 | 745.88M |
| March 04, 2024 | 754.84M |
| March 01, 2024 | 766.04M |
| February 29, 2024 | 766.04M |
| February 28, 2024 | 786.20M |
| February 27, 2024 | 801.88M |
| February 26, 2024 | 766.04M |
| February 23, 2024 | 739.16M |
| February 22, 2024 | 757.08M |
| February 21, 2024 | 766.04M |
| February 20, 2024 | 777.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
518.15M
Minimum
Apr 25 2024
24.58B
Maximum
Dec 09 2020
6.243B
Average
2.674B
Median
Market Cap Benchmarks
| Affimed NV | 81.47M |
| InflaRx NV | 83.03M |
| MorphoSys AG | 2.641B |
| BioNTech SE | 21.68B |
| Immatics NV | 1.112B |
Market Cap Related Metrics
| PS Ratio | 10.02 |
| Price to Book Value | 1.036 |
| Price | 2.64 |
| Earnings Yield | -48.36% |